Home › Funds › ANTIPODES PARTNERS Ltd › META

ANTIPODES PARTNERS Ltd position in META

META PLATFORMS INC · Technology

ANTIPODES PARTNERS Ltd reported holding 245,897 shares of META (META PLATFORMS INC) in its Q3 2026 13F filing — a position valued at US$178.3M, representing 3.29% of its reported portfolio and ranking #5 among its reported holdings. ANTIPODES PARTNERS Ltd has disclosed META holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)245.90K sh
Reported value held$178.32M
Portfolio Weight3.29%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ANTIPODES PARTNERS Ltd's META position evolved

ANTIPODES PARTNERS Ltd first disclosed a stake in META in Q3 2023 at 326,868 shares (US$99.4M). The position peaked in Q3 2026 at 245,897 shares, worth US$178.3M. Across 9 filings, ANTIPODES PARTNERS Ltd increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 245,897 shares valued at US$178.3M — an increase of 63,954 shares quarter over quarter.. Notable position changes include a 46% trim in Q1 2026 (shares fell 3% over the following quarter), a 89% increase in Q2 2026 (shares rose 29% over the following quarter), a 35% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 326.87K $99.35M New
Q4 2023 280.07K $99.13M Reduce
Q1 2024 214.32K $104.07M Reduce
Q2 2024 221.33K $111.60M Add
Q3 2024 148.32K $84.91M Reduce
Q4 2025 179.24K $118.33M New
Q1 2026 96.27K $55.08M Reduce
Q2 2026 181.94K $102.49M Add
Q3 2026 245.90K $178.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About META and 13F data

META (META PLATFORMS INC) is a Technology company. 30 other funds we track also report a position in META — the largest reported positions include Vanguard Group (US$132.02B), VANGUARD CAPITAL MANAGEMENT LLC (US$104.68B), Fidelity Management & Research (FMR) (US$73.55B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding META

All META fund holders →

FAQ

How long has ANTIPODES PARTNERS Ltd held META?

ANTIPODES PARTNERS Ltd has disclosed META holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is ANTIPODES PARTNERS Ltd's current position in META?

As of Q3 2026, ANTIPODES PARTNERS Ltd holds 245.90K shares of META (META PLATFORMS INC), valued at $178.32M, representing 3.29% of its reported portfolio and ranking #5.

Has ANTIPODES PARTNERS Ltd been buying or selling META?

In the latest 13F filing (Q3 2026), ANTIPODES PARTNERS Ltd increased its position in META. The position peaked in Q3 2026 at 245.90K shares.

Which other funds hold META?

Other major institutional holders of META include Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Fidelity Management & Research (FMR), among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.